UPM Biomedicals is the first in the world to manufacture plant-based nanofibrillar cellulose in accordance with ISO13485. Our birch nanocellulose has high quality to fullfil the requirements in life sciences and even in medical applications. Our natural hydrogel is suitable as a key material for injectable fillers, advanced wound care, drug formulation, cell therapy, tissue engineering, but also cell-based models for high throughput screening.
More sustainable than fossil polymers. Produced from sustainable sources.
More biocompatible than cellulose. UPM Biomedicals refines cellulose into high quality nanocellulose for biomedical applications.
ISO 13485 certified. Manufactured in large amounts in reproducible lots: Strict physical and biological quality controls.
Biocompatible. Extensively used for growing cells in research applications like 3D cell culture. Also used for clinical applications for patient treatment. Less risky than materials of animal origin.
Available as shear-thinning non-degradable 3D printable hydrogel or a coated sheet.
UPM creates value from renewable and recyclable materials. In 2023, UPM’s sales were approximately EUR 10.5 billion. UPM has production plants in 10 countries and a global sales network. UPM employs approximately 16,600 employees worldwide. UPM shares are listed on the NASDAQ OMX Helsinki stock exchange. At the end of 2023, UPM had approximately 140,700 shareholders.
We use cookies on this website to ensure the best user experience and target personalised content and relevant advertising. Some cookies are necessary to provide you with a trustworthy service and cannot be declined. Choose the best option for you.
For more information, please see our Privacy Policy.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
UPM Biomedicals
Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Tel. +358 (0)204 15 111
Fax +358 (0)204 15 110